Nektar Therapeutics (NKTR) Shares Issued: 2010-2025
Historic Shares Issued for Nektar Therapeutics (NKTR) over the last 13 years, with Sep 2025 value amounting to $238,000.
- Nektar Therapeutics' Shares Issued was N/A to $238,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2024, which is 99900.00% up from last year.
- Latest data reveals that Nektar Therapeutics reported Shares Issued of $238,000 as of Q3 2025, which was up 12.80% from $211,000 recorded in Q2 2025.
- Over the past 5 years, Nektar Therapeutics' Shares Issued peaked at $30.0 million during Q1 2024, and registered a low of $7,000 during Q1 2025.
- Its 3-year average for Shares Issued is $5.1 million, with a median of $114,500 in 2023.
- In the last 5 years, Nektar Therapeutics' Shares Issued soared by 90.27% in 2021 and then crashed by 99.98% in 2025.
- Over the past 5 years, Nektar Therapeutics' Shares Issued (Quarterly) stood at $1.8 million in 2021, then crashed by 94.28% to $103,000 in 2022, then plummeted by 88.35% to $12,000 in 2023, then reached $30.0 million in 2024, then tumbled by 99.98% to $238,000 in 2025.
- Its last three reported values are $238,000 in Q3 2025, $211,000 for Q2 2025, and $7,000 during Q1 2025.